Verified peer comparison
Kura Oncology vs Intellia Therapeutics Financial Comparison
Direct answer
Kura Oncology and Intellia Therapeutics are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Kura Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Kura Oncology Revenue
- 67,482,000 USD
- Intellia Therapeutics Revenue
- 67,671,000 USD
- Kura Oncology Operating income
- -303,631,000 USD
- Intellia Therapeutics Operating income
- -440,990,000 USD